#34 Weekly Report, 67 Assets Portfolio, Major Announcement, MOAT of Midas Touch is Here.
Carefully curated collection representing a low-turnover, multi-asset, globally diversified approach
Hi fellow investors We’re back with data driven analysis for the week ahead
If you’ve missed it:
I’ve launched my MOAT of Midas Touch high performing portfolios
At Glance:
__________________ (Members)
Short Term Update
Disruption Decoded: Navigating Market Turbulence
Early week updates showed some interesting movements in the tech and biotech sectors:
Iridium Communications ( IRDM 0.00%↑ ) is making waves with a 0.290 fund weight and 40.00k shares. Despite a -0.67% price change, it's garnered 33 Buys, suggesting investor confidence.
Recursion Pharmaceuticals ( RXRX 0.00%↑ ) continues to intrigue with a 0.065 fund weight and 139.00k shares. Its -0.99% price change hasn't deterred buyers, with 122 Buys recorded.
Beam Therapeutics ( BEAM 0.00%↑ ) is seeing some sell-off, with a 0.026 fund weight and 52.00k shares. The -2.29% price change has resulted in 10 Sales.
High-Stakes Balancing Act
The tech sector continues its high-wire act, with some notable performances:
Unity Software ( U 0.00%↑ ) is making headlines with a substantial 1.494 fund weight and 497.00k shares. Despite a -1.69% price change and a -78.54% position change, it's still seeing 7 Sales. This could indicate a strategic repositioning by some major players.
Alphabet ( GOOG 0.00%↑ ) shows resilience with a 0.549 fund weight and 15.00k shares. Its -1.84% price change is offset by a 10.6% position change and 2 Buys, suggesting continued confidence in the tech giant.
Intuit ( INTU 0.00%↑ ) presents a mixed picture with a 0.150 fund weight and 2.00k shares. A 0.89% price change is contrasted by a -5.25% position change and 17 Sales, hinting at some profit-taking.
The Newest Additions
Mid-week updates bring some fresh faces and intriguing developments:
Kindred Biosciences ( KIND 0.00%↑ ) enters the spotlight with a 0.021 fund weight and 107.00k shares. Despite a 1.83% price increase, it's seeing 4 Sales, potentially indicating a "sell on good news" strategy by some investors.
Butterfly Network ( BFLY 0.00%↑ ) makes a subtle entrance with a 0.001 fund weight and 19.00k shares. Its -3.33% price change has resulted in 9 Sales, suggesting caution among investors.
Veracyte ( VCYT 0.00%↑ ) shows volatility with a 0.111 fund weight and 104.00k shares. A -1.46% price change has led to 8 Sales, hinting at some market uncertainty.
DNA Dollars: Wild Genetic Journey
The biotech sector continues its wild ride, with some notable twists and turns:
Twist Bioscience ( TWST 0.00%↑ ) leads the pack with a 0.303 fund weight and 94.00k shares. An impressive 3.79% price jump coupled with a staggering 1938.2% position change and 69 Buys signals strong investor confidence in this synthetic biology player.
Arcturus Therapeutics ( ARCT 0.00%↑ ) shows resilience with a 0.008 fund weight and 5.00k shares. A -0.41% price change hasn't deterred investors, with 21 Buys recorded.
Ginkgo Bioworks ( DNA 0.00%↑ ) makes a splash with a 0.021 fund weight and 994.00k shares. An 8.09% price surge has resulted in 8 Sales, possibly indicating some profit-taking on this synthetic biology stock.
My Strategic Investment Portfolio: A Blueprint for Market Value
In 2018, I initiated this account with an starting investment of $20K, employing a dollar-cost averaging strategy to gradually increase my holdings over time.
Although this is a portfolios, its purpose is twofold: to remain accessible and to provide you with a clear insight into my assessment of market value. This carefully curated collection represents a low-turnover, multi-asset, globally diversified approach, emphasizing liquid investments that can be scaled to accommodate virtually any portfolio size.
